News | February 28, 2025
Cupid receives Rs. 42 crore order from Tanzania
We have big plans across our B2C and B2B businesses in India and abroad
We have big plans across our B2C and B2B businesses in India and abroad
The order, part of an international framework agreement is to be executed between February to April, 2025
The consideration for the acquisition is US $ 2.25 million
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
10+ emerging markets, Japan & ANZ transition in final phase
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
The launch of Elores in Ecuador is expected to open the doors for the entry of the novel antibiotic adjuvant entity in other important Latin American countries
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
Subscribe To Our Newsletter & Stay Updated
